SynthesisEuropean journal of haematology2008

A systematic review of phase II trials of thalidomide/dexamethasone combination therapy in patients with relapsed or refractory multiple myeloma.

Marie von Lilienfeld-Toal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.